IP Library Granted Patent US 8,198,261
Granted Patent B2
US 8,198,261 · App. 10/920,297 · Granted Jun 12, 2012

Thermally modified microbial-derived cellulose for in vivo implantation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,198,261
App. No.
10/920,297
Granted
Jun 12, 2012
Kind
B2
Abstract

A thermally modified microbial-derived cellulose material is described for use as an implantable material in general surgery, plastic surgery and neurosurgery.

Claims (20)

1. A method for preparing an implantable or topical material for general surgery or plastic surgery comprising:

providing a microbial cellulose;

treating said microbial cellulose to render said cellulose non-pyrogenic;

partially dehydrating said microbial cellulose by exposing it to temperatures below 0° C., then exposing said microbial cellulose to temperatures above 0° C.; and

subsequently discarding liquid that was removed,

wherein the general surgery comprises general soft tissue augmentation, pelvic floor reconstruction, bladder neck suspension, hernia repair, or inguinal hernia patch.

2. A method for preparing an implantable or topical material for general surgery or plastic surgery comprising:

providing a microbial cellulose;

treating said microbial cellulose to render said cellulose non-pyrogenic;

partially dehydrating said microbial cellulose by exposing it to temperatures below 0° C., then exposing said microbial cellulose to temperatures above 0° C.; and

subsequently discarding liquid that was removed,

wherein a percentage elongation of the material ranges between 9.3% and 13.3%.

3. A method for implanting an implantable material during a general surgery or a plastic surgery into a subject in need thereof, comprising implanting the material into the subject, wherein the material is prepared by a method comprising:

providing a microbial cellulose;

treating said microbial cellulose to render said cellulose non-pyrogenic;

partially dehydrating said microbial cellulose by exposing it to temperatures below 0° C., then exposing said microbial cellulose to temperatures above 0° C.; and

subsequently discarding liquid that was removed.

4. The method of claim 3 , wherein the general surgery comprises general soft tissue augmentation, pelvic floor reconstruction, bladder neck suspension, hernia repair, or inguinal hernia patch.

5. The method of claim 3 , wherein a percentage elongation of the material ranges between 9.3% and 13.3%.

6. The method of claim 3 , wherein the material is conformable.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNOR PREVIOUSLY RECORDED AT REEL: 039177 FRAME: 0405. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Sep 7, 2016
From: SYNTHES USA PRODUCTS, LLC
To: DEPUY SYNTHES PRODUCTS, INC.
Reel/Frame 039929/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2016
From: SYNTHES USA, LLC
To: DEPUY SYNTHES PRODUCTS, INC.
Reel/Frame 039177/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2014
From: ELLIOT CAPITAL INVESTMENTS III, LTD.
To: SYNTHES USA PRODUCTS, LLC
Reel/Frame 033227/0223 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2012
From: XYLOS CORPORATION
To: ELLIOT CAPITAL INVESTMENTS III, LTD.
Reel/Frame 029120/0401 →
SECURITY AGREEMENT Recorded Jul 26, 2011
From: XYLOS CORPORATION
To: ARGENT CAPITAL INVESTMENTS III, LTD.; FCA INVESTMENT COMPANY; JANSHEN, JOHN; MERCURIUS BELEGGINGSMAATSCHAPPIJ BV; PARTICIPATIEMAATSCHAPPIJ AVANTI LIMBURG BV; STIMEX PARTICIPATIEMAATSCHAPPIJ BV; VROMEN, FRITS F.; ROEST, C.A.W.; JONGEN, C.; WANG, JONAS C.T.; DUTHIE, ANGUS M.; PIETRUSKI, JOHN M.; MCNULTY, MARK S.
Reel/Frame 026653/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2004
From: DAMIEN, CHRISTOPHER JAMES; OSTER, GERRY ANN; BEAM, HEATHER ANN
To: XYLOS CORPORATION
Reel/Frame 015309/0670 →